Arjmand Babak, Hamidpour Shayesteh Kokabi, Tayanloo-Beik Akram, Goodarzi Parisa, Aghayan Hamid Reza, Adibi Hossein, Larijani Bagher
Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Front Genet. 2022 Jan 27;13:824451. doi: 10.3389/fgene.2022.824451. eCollection 2022.
Cancer is defined as a large group of diseases that is associated with abnormal cell growth, uncontrollable cell division, and may tend to impinge on other tissues of the body by different mechanisms through metastasis. What makes cancer so important is that the cancer incidence rate is growing worldwide which can have major health, economic, and even social impacts on both patients and the governments. Thereby, the early cancer prognosis, diagnosis, and treatment can play a crucial role at the front line of combating cancer. The onset and progression of cancer can occur under the influence of complicated mechanisms and some alterations in the level of genome, proteome, transcriptome, metabolome etc. Consequently, the advent of omics science and its broad research branches (such as genomics, proteomics, transcriptomics, metabolomics, and so forth) as revolutionary biological approaches have opened new doors to the comprehensive perception of the cancer landscape. Due to the complexities of the formation and development of cancer, the study of mechanisms underlying cancer has gone beyond just one field of the omics arena. Therefore, making a connection between the resultant data from different branches of omics science and examining them in a multi-omics field can pave the way for facilitating the discovery of novel prognostic, diagnostic, and therapeutic approaches. As the volume and complexity of data from the omics studies in cancer are increasing dramatically, the use of leading-edge technologies such as machine learning can have a promising role in the assessments of cancer research resultant data. Machine learning is categorized as a subset of artificial intelligence which aims to data parsing, classification, and data pattern identification by applying statistical methods and algorithms. This acquired knowledge subsequently allows computers to learn and improve accurate predictions through experiences from data processing. In this context, the application of machine learning, as a novel computational technology offers new opportunities for achieving in-depth knowledge of cancer by analysis of resultant data from multi-omics studies. Therefore, it can be concluded that the use of artificial intelligence technologies such as machine learning can have revolutionary roles in the fight against cancer.
癌症被定义为一大类与细胞异常生长、无法控制的细胞分裂相关的疾病,并且可能通过转移以不同机制侵犯身体的其他组织。癌症如此重要的原因在于,全球癌症发病率正在上升,这会对患者和政府产生重大的健康、经济乃至社会影响。因此,癌症的早期预后、诊断和治疗在抗击癌症的前线可发挥关键作用。癌症的发生和发展可能在复杂机制以及基因组、蛋白质组、转录组、代谢组等水平的某些改变的影响下出现。因此,组学科学及其广泛的研究分支(如基因组学、蛋白质组学、转录组学、代谢组学等)作为具有革命性的生物学方法的出现,为全面了解癌症格局打开了新的大门。由于癌症形成和发展的复杂性,对癌症潜在机制的研究已不仅仅局限于组学领域的一个方面。因此,将组学科学不同分支产生的数据联系起来,并在多组学领域对其进行研究,可为促进发现新的预后、诊断和治疗方法铺平道路。随着癌症组学研究数据的数量和复杂性急剧增加,使用机器学习等前沿技术在评估癌症研究所得数据方面可能会发挥重要作用。机器学习被归类为人工智能的一个子集,其旨在通过应用统计方法和算法进行数据解析、分类和数据模式识别。随后获得的这些知识使计算机能够通过数据处理经验学习并改进准确的预测。在这种背景下,机器学习作为一种新型计算技术的应用,通过分析多组学研究所得数据,为深入了解癌症提供了新的机会。因此,可以得出结论,使用机器学习等人工智能技术在抗击癌症方面可能会发挥革命性作用。